Generalized Epilepsy With Febrile Seizures Plus 7
1 drug in active Generalized Epilepsy With Febrile Seizures Plus 7 trials · Updated 18 Nov 2026
Furthest along
1 in Phase 1
Next Phase 3 result
None yet
Drugs
1
In active trials, any stage
Trials
1 active
No sub-diseases
Drugs1
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Biohaven · Public BHVN |
Phase 1 | Nov 2027Phase 1 trial completes | ||
| Next date | Nov 2027 · Phase 1 trial completes | ||||
| Also tested for | Familial Erythromelalgia | ||||
| Open drug page | |||||
About
- Summary
- 1 drug is in active Generalized Epilepsy With Febrile Seizures Plus 7 trials. Updated 18 Nov 2026.
- Registry term
- Generalized Epilepsy With Febrile Seizures Plus, 7
- Counts
- Active trials the registry tags with the term or a term under it, at any stage. A search also reads trial titles and drug names, so its counts differ.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026